ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

Dana-Farber Opens Imaging Center

May 8, 2009